£182.99

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Other Branches of Medicine

Price data last checked 119 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£183 today · usual range £0–£0 · best ever £150

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 612 days • 612 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 612 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £172-179 (235 days, 38.4%)

Price range: £150 - £186

Price levels: 5 price ranges over 612 days

Description

This book provides basic and applied knowledge about monoamine oxidase inhibitors (MAOIs), their classification, and clinical application as neuroprotective agents and will be a valuable source of new knowledge for doctors, patients, medical students, teachers, researchers, and basic biomedical scientists interested in learning the appropriate clinical application of MAOIs without any misunderstanding for the prevention and/or treatment of neurological and neuropsychiatric disorders. The book will be of immediate interest to patients suffering from Parkinson's disease (PD), Alzheimer's disease (AD), post-traumatic stress disorders (PTSD), panic disorders, attention deficit hyperactivity disorders (ADHD), and major depression. Physicians interested in learning more about MAOIs and their molecular and pharmacological mechanism of action will highly benefit from the book's clinically-interesting contents. In general, this book will be a valuable source of knowledge for the basic researcher, clinically useful for the physician, and therapeutically-beneficial for the patients. The book can also serve as a guide for Masters and Ph.D students interested in conducting research on MAOIs. Particularly, MD doctors, students, and professors will find this book interesting to enhance their basic knowledge about MAOIs and their potential benefits and adverse effects for the better clinical management of drug-resistant PD, AD, and MDDs. Furthermore, recent knowledge regarding the molecular mechanism of MAOIs-mediated protection at the cellular, molecular, and genetic level is thought-provoking and motivates the young scientists to augment research on developing novel drugs with minimum or no adverse effects. It is envisaged that future research on specific CB-targeted MAOIs will have superior pharmacogenomics profiles, enhanced margin of safety, maximum therapeutic index, and minimum or no adverse effects.'

Product Specifications

Format: Hardcover
ASIN: 1634836006
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 01 January 2016
Listed Since: 15 October 2015

Barcode

No barcode data available

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Advances in Neuropharmacology: Drugs and Therapeutics

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Serotonin: From Cell Biology to Pharmacology and Therapeutics

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Cognition and Mood Interactions

Neurobiology of DOPA as a Neurotransmitter

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care

Brain Acetylcholine and Neuropsychiatric Disease

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)